Sun.Jul 21, 2024

article thumbnail

Kamala Harris, endorsed by Biden to replace him, is left of the president on health care

STAT

WASHINGTON — President Biden is ending his bid for a second term in office and backing Vice President Kamala Harris to take the nomination, he announced Sunday. While Harris shares similar views as Biden on many issues, she is to the left of the president on health care. “I believe it is in the best interest of my party and the country for me to stand down and focus solely on fulfilling my duties as president for the remainder of my term,” the president wrote in a letter sha

363
363
article thumbnail

Understanding the Patent Trial and Appeal Board (PTAB) – A Comprehensive Overview

Drug Patent Watch

The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office (USPTO), established in 2012 by the Leahy-Smith America Invents Act (AIA).

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma sector gears up for Budget 2024-25; Calls for innovation and regulatory reforms

Express Pharma

Nandini Piramal, Chairperson, Piramal Pharma, emphasises the need for strengthened regulatory frameworks and strategic partnerships to bolster exports and economic growth in the pharmaceutical sector : “As we approach the upcoming budget, we ’d like to underscore how strengthening regulatory frameworks and fostering strategic public-private partnerships can go a long way in enhancing India’s competitiveness on the global pharmaceutical landscape.

article thumbnail

IT outage raises resilience, security concerns in healthcare

pharmaphorum

As healthcare systems try to recover from major outage event, attention turns to potential fraud and resiliency concerns

102
102
article thumbnail

From Payroll Pains to Growth Gains: Streamlining Payroll & HR for Success

Speaker: Joe Sharpe and James Carlson

In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.

article thumbnail

Medicamen invests $75,000 in Rwanda, expands East African presence

Express Pharma

Medicamen Organics signed a Memorandum of Understanding (MoU) with Depot Pharmacy Yego in Rwanda. This agreement marks the commencement of Medicamen’s operations in Rwanda as a subsidiary, with an initial investment of $75,000. This investment covers capital and product registration costs in the first phase. Medicamen plans to establish its warehouse and depot in Kigali, Rwanda.

81
article thumbnail

What Is Bad About Paroxetine – 3 Strikes and You’re Out

Med Ed 101

Paroxetine is from the family of SSRIs (selective serotonin reuptake inhibitors. It has been around for a long time and is indicated for depression, anxiety, and many other psychiatric indications just like other SSRIs. It doesn’t get much love from healthcare professionals. In this article, I’ll discuss what is bad about paroxetine and why we […] The post What Is Bad About Paroxetine – 3 Strikes and You’re Out appeared first on Med Ed 101.

71

More Trending

article thumbnail

Episode 941: Can non-verbal ICU pain scales indicate the severity of pain?

Pharmacy Joe

In this episode, I’ll discuss whether non-verbal ICU pain scales can indicate the severity of pain. Episode 941: Can non-verbal ICU pain scales indicate the severity of pain? Subscribe on iTunes , Android , or Stitcher The use of pain assessments for patients who are unable to verbally communicate are recommended in the SCCM Pain, Agitation & Delirium Guidelines. 2 examples of such assessments are the Behavioral Pain Scale (BPS) and the Critical Care Pain Observation Tool (CPOT).

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

52
article thumbnail

A throughput benchmarking study of Supor™ Prime filters (July 2024)

PharmaTech

See how Supor Prime filters performed against two comparable products in filtering fluids with antibody concentrations of 70 g/L to 220 g/L. And be sure to request a sample!

52
article thumbnail

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval

Pharmaceutical Technology

Rusan Pharma's new facility in India will enhance its global capabilities and expand its API product portfolio.

52
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Education Curricula Need to Incorporate Whole-Person Care Beyond Electives

Pharmacy Times

Students express interest in whole-person care and identify it as a gap in their education.

48
article thumbnail

Kiniksa Pharmaceuticals sees highest patent filings and grants during April in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Kiniksa Pharmaceuticals here.

52
article thumbnail

Preparing for PrEP: The Implications of PrEP Medicare Coverage Transition for Pharmacies

Pharmacy Times

The shift is intended to maintain uninterrupted access to PrEP, crucial for preventing HIV, and highlights the ongoing efforts to end the HIV epidemic by improving public health outcomes.

26
article thumbnail

Kiniksa Pharmaceuticals sees highest patent filings and grants during April in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Kiniksa Pharmaceuticals here.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Austria?

Drug Patent Watch

This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

52
article thumbnail

Dechra Pharmaceuticals sees highest patent filings and grants during May in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Dechra Pharmaceuticals here.

52
article thumbnail

Where 3 Democrats who could replace Biden atop the ticket stand on health care

STAT

WASHINGTON — President Biden’s decision to drop out of the presidential race has left the Democratic campaign in chaos. “I believe it is in the best interest of my party and the country for me to stand down and to focus solely on fulfilling my duties as President,” Biden wrote in a statement.

349
349
article thumbnail

Oramed Pharmaceuticals sees highest patent filings and grants during April in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Oramed Pharmaceuticals here.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Harris health care agenda swiftly hailed by progressives and reproductive rights groups

STAT

WASHINGTON — President Biden’s announcement Sunday that he would be dropping out of the presidential race left Democrats scrambling to rally around the next likely candidate on the 2024 ticket, Vice President Kamala Harris. The former California senator and attorney general found swift support from progressive and reproductive rights groups that championed her record on abortion policy and maternal health care , two longtime Harris policy priorities that Democrats hope will resonat

article thumbnail

Dechra Pharmaceuticals sees highest patent filings and grants during May in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Dechra Pharmaceuticals here.

52
article thumbnail

Oramed Pharmaceuticals sees highest patent filings and grants during April in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Oramed Pharmaceuticals here.

52
article thumbnail

Y-mAbs Therapeutics sees highest patent filings and grants during June in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Y-mAbs Therapeutics here.

52
article thumbnail

Y-mAbs Therapeutics sees highest patent filings and grants during June in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Y-mAbs Therapeutics here.

52
article thumbnail

iTeos Therapeutics sees highest patent filings and grants during May in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for iTeos Therapeutics here.

52
article thumbnail

iTeos Therapeutics sees highest patent filings and grants during May in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for iTeos Therapeutics here.

52
article thumbnail

Medicover sees highest patent filings and grants during May in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Medicover here.

52
article thumbnail

Medicover sees highest patent filings and grants during May in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Medicover here.

52
article thumbnail

Oscotec sees highest patent filings and grants during June in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Oscotec here.

52
article thumbnail

Certara sees highest patent filings and grants during June in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Certara here.

52
article thumbnail

Oscotec sees highest patent filings and grants during June in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Oscotec here.

52
article thumbnail

Certara sees highest patent filings and grants during June in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Certara here.

52
article thumbnail

Medios sees highest patent filings and grants during May in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Medios here.

52
article thumbnail

Medios sees highest patent filings and grants during May in Q2 2024

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Medios here.

52